Eva Sapi's recent research calls into question everything we thought we knew 
about Lyme "cysts." In fact it destroys the old thinking.
We have heard 
about cell wall antibiotics, intracellular antibiotics and cyst-busters. Think 
again.
She investigated the effect of various antibiotics on Lyme 
spirochetes and round body forms - also know as cystic forms.
Doxycycline 
worked according to plan. Doxy inhibits protein synthesis - it kills bacteria, 
including Lyme, by action within the cytoplasm, inhibiting the manufacture of 
proteins required for the bacteria's survival. Doxy and others are commonly 
referred to as intracellular antibiotics.
Spirochete loads decreased by 
about 90% while cyst levels increased by 200% - just as expected.
Then 
amoxicillin data was presented. Amoxicillin inhibits the formation of bacterial 
cell walls. Amox and similar drugs should then only be effective in killing 
spirochetes with an intact cell wall. This is where the results start deviating 
from the plotted course.
Amoxicillin killed 90% of spirochete forms - OK, 
but -- it also killed 68% of the cystic forms! Amoxicillin and other cell wall 
drugs are not cyst busters - only specific anti-parasite drugs kill cysts - or 
so we thought.
Well lets think again for a second: what are cysts? Are 
they balled up forms of spirochetes with a different kind of membrane - or blebs 
(also described) expressed through the spirochete membrane? Maybe the former 
retain much of the cell wall from the original spirochete - maybe that is why 
amoxicillin works here.
This would seem to clear up a nagging question 
raised by others. Are cysts and L-forms really the same thing? These results 
show that cysts cannot represent a version of L-forms or spheroplasts which 
result when gram negatives shed their cell walls. If this were the case a cell 
wall drug would be ineffective. Cysts and L-forms are distinct and different 
forms. (There may be a hole in this reasoning. I will explain later).
OK 
So we have learned something new: cell wall antibiotics can also kill some cyst 
forms which are not L-forms.
Let's look at some more data. Tigecyline is 
a not a cyst drug either. Wrong. Tigecycline kills 90% of spirochetes, good so 
far, but it also kills 90% of cysts! Tigecycline is an intracellular antibiotic 
similar to doxycycline! Another fly in the ointment.
OK. Cysts with their 
lower metabolic rate, still need ribosomal proteins to survive, just not at the 
levels of intact spirochetes. Tigecyline is a more powerful drug, higher levels 
are delivered into the cytoplasm of the cysts. This makes sense. Cyst forms are 
still essentially a pleomorphic version of Lyme bacteria with somewhat different 
features. In this scenario, cysts could be L-forms. But we have already shown 
that this is not true because amoxicillin can kill them. Right?
Amoxil is 
a cell wall drug. I thought so. Kersten, (antimicrobial agents and chemotherapy, 
May 1995, p. 1127-1133) states that Beta-lactam antibiotics, which include amox, 
penicillin and Rocephin, have been shown to cause a specific loss of total 
intracellular RNA in the absence of cell wall hydrolysis. In other words, amoxil 
could possibly work in part as an intracellular agent. If this is right cyst 
forms of Lyme could still be L-forms. So perhaps we have not shown that L-forms 
and cyst forms are different after all.
The question remains 
unanswered.
Let's get to the Cyst-busters. It takes antiparasitic drugs, 
so we thought, to kill the cysts. Cyst-busters, anti-parasite drugs, kill 
parasites (and Lyme cysts) not bacteria. The so called cyst-busters were 
heretofore used in combination or cycled with other antibiotics. Previous 
thinking was that typical antibiotics would kill spirochetes and/or L-forms and 
that cyst busters would disrupt only the cystic forms.
Cyst-busters do 
not kill intact spirochetes - so we are told. Very wrong this time.
I 
cannot cover the whole Sapi study. The most exciting finding is that Tindamax 
(tinidazole) - our premier Cyst-buster, is the most effective drug overall. This 
"cyst-buster" kills 90% of cysts and spirochetes: by far the best drug. We don't 
know it's effect on L-forms, but we can guess. Tindamax probably works by an 
intracellular mechanism. If this is true it should be equally effective against 
L-forms.
It gets even better. Tindamax is the only drug which does a 
great job on biofilm colonies as well!
(not to be discussed now). More on 
biofilms later.
Tindamax passes the blood brain barrier and penetrates 
well into most tissues. It has been effective in my patients with neurocognitive 
deficits - neuroborreliosis.
Recently I tried it on another sort of 
patient. This patient has had intractable Lyme arthritis of his knees. This 
young athlete had been extensively treated with IV Rocephin followed by a year 
of typical oral antibiotics. Knee effusions have persisted - until I prescribed 
Tindamax. Now, after two months, the fluid in his knees has evaporated. His 
knees are dry and painless for the first time in over one year.
This 
raises the question: should Tindamax be used as mono-therapy? Well, I cannot 
endorse blanket use at this time. Tindamax has a black box warning. It has been 
associated with cancer in some laboratory animals. Perhaps there are more 
compelling reasons to use Tindamax, but this will have to wait for another 
post.
My nagging question:
Why does penicillin kill Lyme? It 
shouldn't. Lyme is a gram negative bacteria. While certain Beta-lactam 
antibiotics can kill gram negative bacteria, penicillin cannot. Penicillin is 
only active against gram positive bacteria.
Maybe this other mechanism 
alluded to above, the alternative intracellular RNA mechanism is significant and 
explains why penicillin kills Lyme spirochetes. Maybe not.
We need to 
continually reevaluate things which we have assumed to be true, because many of 
them are not.
Posted by Lyme report: Montgomery County, MD at 6:31 PM
http://lymemd.blogspot.com/2011/07/e...new-about.html 
 
No comments:
Post a Comment